Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
CellSource Co., Ltd. (JP:4880)
TSE/TYO:4880
Holding JP:4880?
Track your performance easily
4880 Stock Chart & Stats
Day’s Range¥0 - ¥0
52-Week Range¥1,105.00 - ¥1,725.00
Previous Close¥1,139
Volume77.90K
Average Volume (3M)66.64K
Market Cap
¥22.56B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)35.8
Beta0.57
Next Earnings
Dec 12, 2024EPS EstimateN/A
Last Dividend Ex-Date
Oct 30, 2024Dividend Yield0.45%
Share Statistics
EPS (TTM)31.78
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume66,637
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥1,600.00Price Target Upside40.47% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
CellSource Co., Ltd. News
PremiumCompany Announcements
CellSource Co., Ltd. Boosts Employee Stock Incentives
PremiumCompany Announcements
CellSource Launches New Subsidiary for Medical Collaboration
PremiumCompany Announcements
CellSource Co., Ltd. Announces Leadership RestructuringPremiumCompany Announcements
CellSource Backs Kobe City’s Women Empowerment Initiative
PremiumCompany Announcements
CellSource Co. Announces Major Forecast Revisions
PremiumCompany Announcements
CellSource Announces Strategic Acquisition of Medibase
PremiumCompany Announcements
CellSource Co. Unveils Advanced Stem Cell Processing
PremiumCompany Announcements
CellSource Co. Faces Downward Trend in EarningsOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.41% Mutual Funds
― Other Institutional Investors
99.54% Public Companies and
Individual Investors
4880 FAQ
What was CellSource Co., Ltd.’s price range in the past 12 months?
CellSource Co., Ltd. lowest stock price was ¥1105.00 and its highest was ¥1725.00 in the past 12 months.
What is CellSource Co., Ltd.’s market cap?
Currently, no data Available
When is CellSource Co., Ltd.’s upcoming earnings report date?
CellSource Co., Ltd.’s upcoming earnings report date is Dec 12, 2024 which is in 15 days.
How were CellSource Co., Ltd.’s earnings last quarter?
CellSource Co., Ltd. released its earnings results on Sep 12, 2024. The company reported ¥3.75 earnings per share for the quarter, beating the consensus estimate of N/A by ¥3.75.
Is CellSource Co., Ltd. overvalued?
According to Wall Street analysts CellSource Co., Ltd.’s price is currently Undervalued.
Does CellSource Co., Ltd. pay dividends?
CellSource Co., Ltd. pays a Semiannually dividend of ¥5 which represents an annual dividend yield of 0.45%. See more information on CellSource Co., Ltd. dividends here
What is CellSource Co., Ltd.’s EPS estimate?
CellSource Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CellSource Co., Ltd. have?
CellSource Co., Ltd. has 19,806,100 shares outstanding.
What happened to CellSource Co., Ltd.’s price movement after its last earnings report?
CellSource Co., Ltd. reported an EPS of ¥3.75 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.73%.
Which hedge fund is a major shareholder of CellSource Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4880
---
CellSource Co., Ltd. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technical Analysis
StemRIM Inc.
―
Immuno-Biological Laboratories Co., Ltd.
―
Healios KK
―
STELLA PHARMA CORPORATION
―
Best Analysts Covering 4880
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-17.10%
reiterated a buy rating 3 months ago
Copying Kota Maeda's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -17.10% per trade.
---